Fat distribution in obese women is associated with subtle alterations of the hypothalamic–pituitary–adrenal axis activity and sensitivity to glucocorticoids
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
OBJECTIVES Obesity with abdominal body fat distribution (A‐BFD) and hypothalamic‐pituitary‐adrenal (HPA) axis activity are somehow linked, but the exact interactions still need clarification. Obese subjects display normal circulating plasma cortisol concentrations with normal circadian rhythms. However, when the HPA axis is pharmacologically challenged, body fat distribution matters and then A‐BFD obese women differ from those with subcutaneous body fat distribution (P‐BFD). We hypothesized that lower dose provocative and suppressive tests than those used to diagnose hypercortisolism of tumour origin or adrenal insufficiency would shed some light on the characteristics of the HPA axis activity in relation with body fat distribution. PATIENTS AND METHODS Fifty premenopausal obese women were grouped according to their body fat mass distribution. Their plasma cortisol responses to (i) two low doses of dexamethasone (0·25 and 0·5 mg) with (ii) low dose of the ACTH analogue tetracosactrin (1 µg) were assessed. Salivary cortisol was also determined during the ACTH test. RESULTS A‐BFD differed from P‐BFD women in terms of HPA axis responsiveness. They had comparatively: (i) increased nocturnal cortisol excretion (9·38 ± 2·2 vs. 6·82 ± 0·91 nmol/µmol creatinine, A‐BFD vs. P‐BFD, respectively, P = 0·03); (ii) increased salivary cortisol response to ACTH stimulation (1 µg) [salivary cortisol peak: 33·4 (14·1–129) vs. 28·5 (13·2–42·8) nmol/l; salivary AUC: 825 (235–44738) vs. 537 (69–1420) nmol/min/l; A‐BFD vs. P‐BFD, P = 0·04 for both]; and (iii) increased pituitary sensitivity to dexamethasone testing [postdexamethasone (0·25 mg) plasma cortisol levels: 163 (26–472) vs. 318 (26–652) nmol/l and postdexamethasone (0·5 mg) plasma cortisol levels: 26 (26–79) vs. 33 (26–402) nmol/l; A‐BFD vs. P‐BFD, P = 0·01 for both). CONCLUSIONS These data demonstrate differences in the HPA axis activity and sensitivity to glucocorticoids between obese women differing in their body fat distribution, with both enhanced negative and positive feedback in those with abdominal obesity. Several mechanisms may explain these differences: central vs. peripheral hypotheses. Thus, abdominal obesity does not appear to be linked solely to one pathophysiological hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 1×
“Both are characterized by centralization of body fat and abnormal endocrine, metabolic and cardiovascular features described as a `functional Cushing's syndrome' in abdominal obesity (Bujalska et al., 1997).”
BackgroundGlucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 1×
“…overnight cortisol secretion may explain the relatively higher blood glucose levels in A-BFD subjects (positive relationship between fasting glycaemia and overnight UFC levels), suggesting that an enhanced activity of cortisol could contribute to insulin resistance (Andrew & Walker, 1999).”
BackgroundCortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Lambillotte, C., Gilon, P., & Henquin, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119175 · Cited by 419 · cited 1×
“Glucocorticoids in vivo impair insulin-dependent glucose uptake in the periphery, enhance gluconeogenesis in the liver and inhibit insulin secretion in vitro from pancreatic b-cells (Lambillotte et al., 1997).”
BackgroundStewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
LAUDAT, M. H., CERDAS, S., FOURNIER, C., GUIBAN, D., GUILHAUME, B., & LUTON, J. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-343 · Cited by 393 · cited 2×
“, 1998) demonstrating a difference between plasma cortisol and saliva cortisol in lean subjects during ACTH stimulation, the cortisol response to ACTH was measured both in plasma and saliva, with salivary cortisol concentrations closely reflecting the free-active-plasma cortisol (Laudat et al., 1988).”
BackgroundPasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A. M., & Barbara, L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8393881 · Cited by 366
Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
Plat, L., Leproult, R., L’Hermite-Baleriaux, M., Fery, F., Mockel, J., Polonsky, K. S., & Van Cauter, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5978 · Cited by 225 · cited 2×
“Finally, activation of the HPA axis results in more severe metabolic consequences when occurring during the diurnal nadir of circadian activity because physiological elevation of plasma cortisol levels in the evening has more pronounced effects on glucose regulation than elevation of cortisol levels in the morning (Pl…”
BackgroundPlat, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3082 · Cited by 177
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“While individuals with idiopathic abdominal obesity share several of the morphological and metabolic alterations observed in Cushing’s syndrome, alterations in the sensitivity and drive of the hypothalamo-pituitary-adrenal (HPA) axis have been shown to be much more subtle (131, 345, 416).”
BackgroundAre Mood Disorders and Obesity Related? A Review for the Mental Health Professional
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 652
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 443
Rask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Metadata
- Authors
- Duclos, M., Gatta, B., Corcuff, J. ‐., Rashedi, M., Pehourcq, F., & Roger, P.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 55
- Issue
- 4
- Pages
- 447-454
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2016978154
- Cited by
- 105
- References
- 11
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fat distribution in obese women is associated with subtle alterations of the hypothalamic–pituitary–adrenal axis activity and sensitivity to glucocorticoids. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01384.x
- The paper
- Duclos, M., Gatta, B., Corcuff, J. ‐., Rashedi, M., Pehourcq, F., & Roger, P. (2001). Fat distribution in obese women is associated with subtle alterations of the hypothalamic–pituitary–adrenal axis activity and sensitivity to glucocorticoids. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01384.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.